Today, many companies are trying to solve global health challenges through philanthropy. However, it has become clear that philanthropy alone is no longer enough to make a lasting impact.

In a medical treatment facility on the Thai-Burmese border, 21 patients infected with malaria recently participated in a clinical trial.

We’re working to bring the hope of advanced medicine to more patients.

Boston University developed a methodology to evaluate the impact of Novartis Access in Kenya. Peter C. Rockers tells us about the ongoing study.

COPD receives low attention as a women’s health issue. It’s time to change that.

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

Global Oncology Patient Insights Panels (GOPIPs) are giving patients and advocates a critical voice in advancing lung cancer trials.

Elyse Spatz Caplan’s cancer diagnosis impacted her life in more ways than 1

New Global Head of Ophthalmology Research sees the eye as a frontier of biomedical research.

Novartis researchers are using new technologies, such as DNA-encoded libraries, to find new ways to treat disease.